This post is not the latest immunisation update and therefore may contain information or advice that is out of date. Please see our most recent update here.
As we enter the cold and flu season, encourage patients to get vaccinated against the flu. Last year saw a significantly reduced flu season, and behaviours like increased hand washing and physical distancing helped to stop the spread of influenza viruses in the community.
Flu vaccination is recommended for everyone over the age of 6 months and is free for:
people aged 65 years and over
pregnant women (at any stage during pregnancy)
all Aboriginal and Torres Strait Islander people aged 6 months and over
all children aged 6 months to less than 5 years
people aged 6 months and over with certain medical conditions that increase their chance of severe influenza and its complications.
Important reminders:
An interval of 14 days between the COVID-19 vaccine and the flu vaccine is required, regardless of which vaccine is administered first.
All influenza vaccinations administered must be reported to the Australian Immunisation Register (AIR).
If patients experience an adverse event following the administration of a COVID-19 vaccine, these must be reported, and standard adverse event reporting practices should be followed.
All uncommon, serious or unexpected adverse events or any event felt to be significant that occurs after having a vaccination should be reported.
How to report a suspected AEFIs – anyone can submit reports directly to the TGA and PHU:
Contact your Public Health Unit (PHU) on 1300 066 055
Updated – ATAGI clinical guidance on COVID-19 vaccine in Australia in 2021
The Australian Technical Advisory Group on Immunisation (ATAGI) has updated its clinical guidance for immunisation providers and program staff on the use of COVID-19 vaccines.
Changes from the previous version (v2.0) include: information on thrombosis with thrombocytopenia syndrome (TTS), a newly identified condition very rarely associated with COVID-19 Vaccine AstraZeneca.
Updated vaccine recommendations:
Comirnaty preferred over COVID-19 Vaccine AstraZeneca for people aged <50 years and for people with a past history of cerebral venous sinus thrombosis (CVST) or heparin induced thrombocytopenia (HIT)
updated guidance on vaccine storage and handling
updated information on SARS-CoV-2 variants of concern
updated list of medical conditions associated with an increased risk of severe illness.
In-reach COVID-19 vaccinations for aged care workers
The Department encourages primary care providers to administer in-reach vaccination services to residential aged care staff if requested by a facility or the relevant Primary Health Network (PHN).
This will support timely access to COVID-19 vaccinations for the residential aged care workforce.
These clinics can be timed to align with health care attendances for aged care residents where eligible practitioners can claim a flag fall to assist in the cost of travelling to a residential aged care facility.
There is an AstraZeneca vaccine batch (PW40043, PW40038 and PV46672) due to expire on 30 June 2021. Check the batch expiry dates on your vaccines and rotate the stock appropriately to minimise the risk of expired vaccine doses.
General practices not participating in the COVID-19 vaccination program
General practices not in the vaccination program are encouraged to direct patients to the COVID-19 Vaccine Eligibility Checker. Using this tool, patients will be able to find out when they’ll be eligible for vaccination.
If they are eligible, they can find a clinic near them to book an appointment.
If they are not eligible, they can register their interest to be notified, either by email or SMS, when COVID-19 vaccination is available to them.
COVID-19 vaccine updates for GPs
Join the latest COVID-19 vaccine live stream update for GPs.
The panel will provide latest key updates and answer participants’ questions live about the COVID-19 vaccine rollout.
The Australian Academy of Science has launched a new guide about the science of immunisation to help counter misinformation and uncertainty surrounding vaccines for COVID-19 and other diseases.
Maroubra Medicare Urgent Care Clinic (UCC) is now open The Maroubra Medicare Urgent Care Clinic (UCC) is now open, seven days a week, from 8.00am to 8.00pm. It was officially launched by member for Kingsford Smith, the hon Matt Thistlethwaite MP (pictured at the launch with CESPHN CEO Nathalie Hansen…
Media Release: Central and Eastern Sydney PHN releases Healthy Ageing Strategy to empower older people In response to the increasing longevity and rapid growth of the older population the Central and Eastern Sydney Primary Health Network (CESPHN) is proud to release its new Healthy Ageing Strategy 2023-2028. This comprehensive strategy…
Immunisation Weekly Update: Are your vaccines ready for summer? In the summer season, storms are more likely to occur, which can lead to power outages. Refer to the Cold Chain Toolkit to ensure all vaccination storage requirements are in place should an outage occur. Disposal of Zostavax® Zostavax® vaccine will…
Immunisation Weekly Update: COVID-19 XBB.1.5 vaccine onboarding The Australian Government has accepted the latest advice from ATAGI on the use of the new COVID-19 XBB 1.5 vaccine as part of the National COVID-19 Vaccine Program. All sites currently participating in the COVID-19 Vaccination Program will be onboarded for the three…
Immunisation Weekly Update: Increase in COVID-19 infection cases ATAGI notes a recent increase in COVID-19 cases since November 2023 across Australia and encourages all eligible people who have not yet had their recommended 2023 COVID-19 vaccine dose/s to receive them as soon as possible. A first 2023 dose is recommended…
Immunisation Weekly Update: Vaccination coverage in RACF Australian Immunisation Register (AIR) data suggests that only 36% of people aged 70+ living in the central and eastern Sydney PHN region are immunised against Pneumococcal diseases. Immunisation providers are reminded to check AIR immunisation history statements of patients going into Residential Aged…
Immunisation Weekly Update: Introduction of Shingrix® to the NIP From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles. A…
NSW urged to prepare for heat wave Severe heatwave conditions are forecast in NSW in the coming days. Please read the NSW Health media release about taking steps to prevent heat-related illness. For further information about staying safe in a heatwave, visit Beat the heat and stay well during hot…